APA (7th ed.) Citation

JY, C., XY, T., SS, W., W, X., RR, P., LL, C., . . . MQ, H. (2023). Magnolol as STAT3 inhibitor for treating multiple sclerosis by restricting Th17 cells. Phytomedicine : international journal of phytotherapy and phytopharmacology, 117, 154917. https://doi.org/10.1016/j.phymed.2023.154917

Chicago Style (17th ed.) Citation

JY, Chen, et al. "Magnolol as STAT3 Inhibitor for Treating Multiple Sclerosis by Restricting Th17 Cells." Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 117 (2023): 154917. https://doi.org/10.1016/j.phymed.2023.154917.

MLA (9th ed.) Citation

JY, Chen, et al. "Magnolol as STAT3 Inhibitor for Treating Multiple Sclerosis by Restricting Th17 Cells." Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 117, 2023, p. 154917, https://doi.org/10.1016/j.phymed.2023.154917.